Howard Horn Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

Howard Horn is Chief Financial Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 106,169 shares of RARE, which is worth approximately $3.91 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 1,785 shares (Common Stock) at a price of $40.4 per share, resulting in proceeds of $72,114. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K
0% 3M change
6.42% 12M change
Total Value Held $3.91 Million

Howard Horn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2025
SELL
Open market or private sale
$72,114 $40.4 p/Share
1,785 Reduced 1.65%
106,169 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
-
15,653 Added 12.66%
107,954 Common Stock
Oct 10 2024
SELL
Open market or private sale
$393,853 $52.76 p/Share
7,465 Reduced 7.48%
92,301 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
19,400 Added 16.28%
99,766 Common Stock
Oct 09 2023
BUY
Grant, award, or other acquisition
-
80,366 Added 50.01%
80,336 Common Stock

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
CFO
HH

Howard Horn

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE